Osaic Holdings’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Osaic Holdings’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-12	Closed	–	–	6728
2020 Q3	$0	Buy	+12	New	+$293	﹤0.01%	6547

Other funds holding CNST

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Osaic Holdings's CNST Position: Q4 2020 in Review

Osaic Holdings sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q4 2020, closing a stake of 12 shares.

Osaic Holdings first reported a position in CNST in Q3 2020 and held it in 1 quarter. The position peaked at $0 in Q3 2020. 134 funds tracked by Wall St. Rank hold CNST as of Q4 2020.

Osaic Holdings reported no remaining Constellation Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Osaic Holdings sold 12 Constellation Pharmaceuticals, Inc. shares in Q4 2020.
Osaic Holdings first reported a position in Constellation Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
Osaic Holdings's Constellation Pharmaceuticals, Inc. position peaked at $0 in Q3 2020.
134 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q4 2020.

Based on Osaic Holdings's 13F filing for Q4 2020, filed 10 Feb 2021.